Theravance Biopharma to Present at the Credit Suisse 27th Annual Healthcare Conference

DUBLIN /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that management will present a corporate overview at the Credit Suisse 27th Annual Healthcare Conference on Wednesday, November 14, 2018, at 8:35 a.m. MST.  The conference will be held from November 12 - 15 at the Phoenician in Scottsdale, AZ.

A live broadcast will be available by visiting the Investor Relations section of Theravance Biopharma's website at www.theravance.com, under the Presentations & Events tab. Listeners are encouraged to visit the site at least 15 minutes prior to the scheduled presentation to register, download and install any necessary audio software. Audio replays will be available for 30 days following the presentation.


THERAVANCE®, the Cross/Star logo, and VIBATIV® are registered trademarks of the Theravance Biopharma group of companies.

Contact Information:

Alexander Dobbin
Head of Investor Relations 
650-808-4045 
investor.relations@theravance.com

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Theravance Biopharma

Theravance Biopharma, Inc. ("Theravance Biopharma") is a diversified biopharmaceutical company with the core purpose of creating medicines that help improve the lives of patients suffering from serious illness.